Data on obesity-PCa link mount, but conflict
February 15th 2004Las Vegas--Obesity in prostate cancer patients is associated withhigher-grade tumors, cancer recurrence, and more aggressive disease, recentstudies have shown. The research has prompted some urologists to suggestusing body mass index (BMI) as a marker for early screening and treatment.Others suggest that further studies should be undertaken to determine ifweight loss may, in fact, lower prostate cancer risk.
Data reveal shift in prostate Ca treatment choices
February 15th 2004Las Vegas--Brachytherapy is a growing treatment choice for menwith low-risk prostate cancer, although it is still selected by less than22% of men with the disease, according to San Francisco researchers. Theuse of androgen ablation has also increased, the researchers found in ananalysis of data from the CaPSURE database.
Dr. Kuo joins urology department at Thomas Jefferson
February 5th 2004Urologist Ramsay L. Kuo, MD, has joined the department of urology at Thomas Jefferson University Hospital, Philadelphia, with an appointment as assistant professor of urology, Jefferson Medical College of Thomas Jefferson University.
Group establishes guidelines for drug studies of relapsed prostate Ca patients
February 5th 2004A group of three leading cancer centers has developed guidelines to determine which prostate cancer patients at risk for relapse should participate in a clinical trial and which compounds are appropriate in these studies.
NIDDK invites applications on research into epidemiology of interstitial cystitis
February 5th 2004The National Institute of Diabetes and Digestive and Kidney Diseases has announced a request for applications (RFA) for a study entitled, "Interstitial Cystitis/Painful Bladder Syndrome: Epidemiology" (RFA-DK-04-009).
Anticholinergic drug effective in treating severe overactive bladder, study shows
February 5th 2004A sustained-release anticholinergic drug provides appears to be beneficial in the reduction of urge incontinence for patients with either severe or moderate symptoms of overactive bladder, according to results of a study published in the February issue of The Journal of Urology (2004; 171:752-6).
Testosterone replacement therapy not linked to prostate cancer, analysis finds
February 5th 2004There is no causal relationship between testosterone replacement and prostate cancer or heart disease risk, according to a retrospective analysis by researchers at Beth Israel Deaconess Medical Center, published last week in The New England Journal of Medicine (2004; 350:482-92).
How to diagnose and treat late-onset hypogonadism
February 1st 2004The last few years have witnessed an enormous interest in androgen replacement therapy for late-onset hypogonadism-also known as "androgen deficiency in the aging male." As urologists, we frequently deal with sexual dysfunction and are seen as experienced on issues of prostate health.
Lap nephroureterectomy: Mid-term results show promise
February 1st 2004Montreal--Laparoscopic nephroureterectomy is becoming a widely utilized option in the surgical treatment of upper tract transitional cell carcinoma. As more centers accrue larger series with longer follow-up, assessment of surgical as well as oncologic results is possible and necessary.
How to make a high-quality poster using PowerPoint
February 1st 2004All of us see great clinical cases from time to time and make valuableobservations. Often there is an opportunity to present this material asa poster at scientific meetings. Until recently, the production of a high-qualityscientific poster required the use of an outside graphic arts firm at acost of more than $1,000.
Varicocele repair offers potential to help infertile men
February 1st 2004Varicocele is a common clinical finding, present in approximately 15%of adult men. When the patient with a varicocele visits a urologist, itis often due to testicular discomfort or fertility-related concerns. Atthe 2003 meeting of the American Society for Reproductive Medicine, bothof these issues were addressed and are discussed in this issue of UrologyTimes.
Natural conception possible after varicocele repair
February 1st 2004San Antonio--Repair of clinically significant varicoceles may resultin nearly a 25% chance of natural conception, even in men who do not demonstratesignificant improvements in their postoperative seminal parameters, accordingto University of Iowa researchers.
Polishing the 'gold standard' in vasovasostomy
February 1st 2004San Antonio--Biomaterial wraps are a promising adjunct for vasovasostomy,according to results of an animal study that incorporated a biomaterialmatrix and a sealant into the conventional three-suture anastomosis. Researcherscalled this "polishing the gold standard" because of the highpatency rate of the standard procedure.
Take advantage of new tax rules when filing returns
February 1st 2004Our income tax law, the Internal Revenue Code, turned 90 in 2003. Whatstarted as a 400-page tax bill when Woodrow Wilson signed it into law in1913 now contains more than 55,000 pages. In fact, last year, Congress passedand the president quickly signed into law a $330 billion, 10-year tax cutplan-The Jobs and Growth Tax Relief Reconciliation Act of 2003. That billboth added to the page count and made a significant impact on the tax billsof many physician practices.
Cancer patients' semen is preserved late, used little
February 1st 2004San Antonio--A retrospective study of men with cancer who elected to cryopreservetheir sperm because of cancer therapy found that 20% of men had alreadyreceived one or more cycles of chemotherapy. The recognized toxic effectsof chemotherapy and radiation on sperm cells make this a questionable practice
Use -59 modifier when billing for indwelling stent
February 1st 2004Q I am in a multiple-physician urology practice. One of our physiciansbelieves that billing 52332 with 52352 or 52353 with a 59 modifiershould be paid, and that billing 52005 with 52332 with the 59 modifiershould be paid (ie, 52005-59). When is it appropriate to use the 59modifier?
The Wet Patient: Understanding Overactive Bladder and Urge Incontinence
February 1st 2004Scott Serels, MD, Director, Bladder Control Center of Norwalk, Connecticut This Urology Times supplement was produced by Advanstar Communications, Inc, under an unrestricted educational grant from Ortho-McNeil Pharmaceutical, Inc.The views and opinions expressed in this supplement do not necessarily reflect the views of Advanstar Communications, Inc or Ortho-McNeil Pharmaceutical, Inc.Sponsored and supported by a grant from Ortho-McNeil Pharmaceutical, Inc.Cover image ?Bryson BioMedical/Custom Medical Stock Photo.Copyright ?2004 Advanstar Communications, Inc. All rights reserved.
Good and bad news: ED patients often don't return
February 1st 2004Quebec City, Quebec--The good news is that most patients being treated for erectile dysfunction report that their treatment is working. The bad news is that a significant percentage of these same patients are often lost to follow-up for that very reason, according to a study by urologists from McGill University.
University of Nebraska receives grant to study cell signaling in prostate Ca
January 22nd 2004The University of Nebraska Medical Center has received a 5-year grant totaling almost $9.9 million from the National Institutes of Health to further the understanding of cell signaling in relation to a variety of cancers, including cancer of the prostate.
For-profit and not-for-profit health plans similar in allowing high-cost procedures
January 22nd 2004The rate of use of high-cost operative procedures is not lower among Medicare beneficiaries enrolled in for-profit health plans than among those enrolled in not-for-profit health plans, according to a study in the New England Journal of Medicine (2004; 350:143-150).